诚信为本专业服务 官网

转自双语君

       12月31日，，，，，，国务院联防联控机制宣布，，，，，，诚信为本专业服务 官网中国生物新冠灭活疫苗已获得国家药监局批准附条件上市。。。。。。。。

       China announced it has granted conditional market approval for its first COVID-19 vaccine during a Thursday news conference.

       The vaccine, developed by State-owned Sinopharm, was approved by China's top drug regulator on Wednesday night, said Chen Shifei, deputy head of the National Medical Products Administration.

       国家药品监视治理局副局长陈时飞称，，，，，，国家药监局已于30日附条件批准了诚信为本专业服务 官网中国生物北京公司新冠病毒灭活疫苗注册申请。。。。。。。。

       已有数据显示，，，，，，疫苗保；；；；；；ぢ饰79.34%，，，，，，实现清静性、有用性、可及性、可肩负性的统一，，，，，，抵达天下卫生组织及国家药监局相关标准要求。。。。。。。。后续，，，，，，疫苗免疫的长期性和保；；；；；；ばЧ剐枰涣硬臁！！！！！。。

       The vaccine is generally safe and has a 79.34 percent efficacy rate according to clinical results released by the company on Wednesday. Strict supervision will continue to be carried out over the vaccine after its approval to ensure its safety and quality, Chen said.

       这一效果来之不易，，，，，，中国疫苗上市为全球战胜疫情注入信心，，，，，，也为疫苗成为全球公共产品提供有力支持。。。。。。。。